These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 11054231)

  • 21. Adenovirus-mediated VEGF gene therapy enhances venous thrombus recanalization and resolution.
    Modarai B; Humphries J; Burnand KG; Gossage JA; Waltham M; Wadoodi A; Kanaganayagam GS; Afuwape A; Paleolog E; Smith A
    Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1753-9. PubMed ID: 18669887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients.
    Salgado R; Vermeulen PB; Benoy I; Weytjens R; Huget P; Van Marck E; Dirix LY
    Br J Cancer; 1999 May; 80(5-6):892-7. PubMed ID: 10360671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and soluble interleukin-2 receptor (sIL-2R) concentrations in peripheral blood as markers of pituitary tumours.
    Komorowski J; Jankewicz J; Stepień H
    Cytobios; 2000; 101(398):151-9. PubMed ID: 10755214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human granulocyte colony-stimulating factor enhanced the resolution of venous thrombi.
    Chen YK; Jiang XM; Gong JP
    J Vasc Surg; 2008 May; 47(5):1058-65. PubMed ID: 18358673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VEGF and bFGF are highly expressed in intraluminal fibromyxoid lesions in bronchiolitis obliterans organizing pneumonia.
    Lappi-Blanco E; Soini Y; Kinnula V; Pääkkö P
    J Pathol; 2002 Feb; 196(2):220-7. PubMed ID: 11793374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants.
    Majima M; Hayashi I; Muramatsu M; Katada J; Yamashina S; Katori M
    Br J Pharmacol; 2000 Jun; 130(3):641-9. PubMed ID: 10821793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Independent expression of serum vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients with carcinoma and sarcoma.
    Linder C; Linder S; Munck-Wikland E; Strander H
    Anticancer Res; 1998; 18(3B):2063-8. PubMed ID: 9677468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular endothelial growth factor in chronic subdural haematomas.
    Shono T; Inamura T; Morioka T; Matsumoto K; Suzuki SO; Ikezaki K; Iwaki T; Fukui M
    J Clin Neurosci; 2001 Sep; 8(5):411-5. PubMed ID: 11535006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells.
    Nakamura S; Murakami-Mori K; Rao N; Weich HA; Rajeev B
    J Immunol; 1997 May; 158(10):4992-5001. PubMed ID: 9144519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
    Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia and upregulation of hypoxia-inducible factor 1{alpha} stimulate venous thrombus recanalization.
    Evans CE; Humphries J; Mattock K; Waltham M; Wadoodi A; Saha P; Modarai B; Maxwell PH; Smith A
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2443-51. PubMed ID: 20930171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between vessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in small cell lung cancer in vivo and in vitro.
    Lund EL; Thorsen C; Pedersen MW; Junker N; Kristjansen PE
    Clin Cancer Res; 2000 Nov; 6(11):4287-91. PubMed ID: 11106245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis.
    Braybrooke JP; O'Byrne KJ; Propper DJ; Blann A; Saunders M; Dobbs N; Han C; Woodhull J; Mitchell K; Crew J; Smith K; Stephens R; Ganesan TS; Talbot DC; Harris AL
    Clin Cancer Res; 2000 Dec; 6(12):4697-704. PubMed ID: 11156222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients.
    Brattström D; Bergqvist M; Larsson A; Holmertz J; Hesselius P; Rosenberg L; Brodin O; Wagenius G
    Anticancer Res; 1998; 18(2A):1123-7. PubMed ID: 9615776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated serum vascular endothelial growth factor and basic fibroblast growth factor levels in patients with thymic epithelial neoplasms.
    Sasaki H; Yukiue H; Kobayashi Y; Nakashima Y; Moriyama S; Kaji M; Kiriyama M; Fukai I; Yamakawa Y; Fujii Y
    Surg Today; 2001; 31(11):1038-40. PubMed ID: 11766079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coexpression of VEGF and bFGF in human epidermoid lung carcinoma is associated with increased vessel density.
    Mattern J; Koomägi R; Volm M
    Anticancer Res; 1997; 17(3C):2249-52. PubMed ID: 9216696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma vascular endothelial but not fibroblast growth factor levels correlate with colorectal liver mestastasis vascularity and volume.
    Davies MM; Jonas SK; Kaur S; Allen-Mersh TG
    Br J Cancer; 2000 Mar; 82(5):1004-8. PubMed ID: 10737380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of bFGF, FGFR-1 and VEGF expression with vascularity and malignancy of human astrocytomas.
    Bian XW; Du LL; Shi JQ; Cheng YS; Liu FX
    Anal Quant Cytol Histol; 2000 Jun; 22(3):267-74. PubMed ID: 10872046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus.
    Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
    Lupus; 2002; 11(6):348-55. PubMed ID: 12139372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.